Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > July 12, 2023
Daily News
July 12, 2023
- Meiji to Develop Lineup Unaffected by Price Revisions, Bolster Earnings from New Drugs/Generics in Focus Areas
July 12, 2023
- MHLW Certifies Antibiotics Supply Assurance Plans from Meiji, Fujifilm, Otsuka
July 12, 2023
- Reform Regenerative Medicine Systems to Fight Lag, Loss: FIRM to Japan Govt
July 12, 2023
- SanBio to Ax 22 Jobs in US, Focus on Work towards Japan Cell Therapy Launch
July 12, 2023
- RaQualia’s Acid Reducer Tegoprazan Launched in Indonesia
July 12, 2023
- JCR Grabs German OK for Launch of Global PI/II for MPS IIIA Drug
July 12, 2023
- Eisai’s Alzheimer’s Skipper to Retire after Full Leqembi Approval
July 12, 2023
- MHLW Panel OKs 172 More Health Damage Claims for COVID Vaccines
July 12, 2023
- Astellas Bags Rights to 4DMT’s Gene Therapy Vector for Eye Diseases
July 12, 2023
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…